A new hypothesis for the etiopathogenesis of the Alzheimer's syndrome. Advanced glycation endproducts (AGEs);Neue Hypothese zur Atiopathogenese des Alzheimer-Syndroms. Advanced glycation endproducts (AGEs)

Nervenarzt

Volumn 67, Issue 11, 1996, Pages 924-929

  Thome, J ^a   Kornhuber, J ^a   Munch G ^a   Schinzel, R ^a   Taneli, Y ^a   Zielke, B ^a   Rosler M ^a   Riederer, P ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

advanced glycation endproducts; AGE; Alzheimer's disease; biochemical hypotheses; etiology

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMYLOID BETA PROTEIN; RECEPTOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; GLYCATION; HUMAN; OXIDATION; REVIEW;

EID: 0029833134     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050073     Document Type: Review

References (36)

1. Adams IM (1991) Structural plasticity of synapses in Alzheimer's disease. Mol Neurobiol 5: 411-419
2. Alzheimer A (1907) Über eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiatr 64: 146-148
3. Alzheimer A (1911) Über eigenartige Krankheitsfälle des späteren Alters. Z Gesamte Neurol Psychiatrie 4: 356-385
4. Bauer J (1994) Die Alzheimer-Krankheit. Neurobiologie, Psychosomatik, Diagnostik und Therapie. Schattauer, Stuttgart New York
5. Blum-Degen D, Frölich L, Hoyer S, Beckmann H, Riederer P (1994) Insulin und Insulinrezeptoren bei der Demenz vom Alzheimer-Typ. Fortschr Neurol Pschiatr [Suppl 2] 62: 59-60
6. Connor JR, Menzies SL, Martin SM St, Mufson EJ (1992) A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brain. J Neurosci Res 31: 75-83
7. Cras P, Smith MA, Richey PL, Siedlak SL, Mulvihill P, Perry P (1995) Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease. Acta Neuropathol (Berl) 89: 291-295
8. Gerlach M, Ben-Shachar D, Riederer P, Youdim MB (1994) Altered brain metabolism of iron as a cause of neurodegenerative disease? J Neurochem 63: 793-807
9. Götz ME, Künig G, Riederer P, Youdim MB (1994) Oxidative stress: free radical production in neural degeneration. Pharmacol Ther 63: 37-122
10. Greenamyre JT, Maragos WF (1993) Neurotransmitter receptors in Alzheimer disease. Cerebrovasc Brain Metab Rev 5: 61-94
11. Gsell W, Conrad R, Hickethier M, Sofic E, Frölich L, Wichart I, Jellinger K, Moll G, Ransmayr G, Beckmann H, Riederer P (1995) Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type. J Neurochem 64: 1216-1223
12. Harrington CH, Colaco CALS (1994) Alzheimer's disease. A glycation connection. Nature 370: 247-248
13. Hoyer S (1991) Abnormalities of glucose metabolism in Alzheimer's disease. Ann N Y Acad Sci 640: 53-58
14. Ihl R, Perisic I, Maurer K, Dierks T (1989) Effect of 3 months treatment with tensilsetam in patients suffering from dementia of Alzheimer type (DAT). J Neural Transm Park Dis Dement Sect 1: 84-85
15. Jones DG (1993) Synaptic plasticity and perforated synapses: their relevance for an understanding of abnormal synaptic organization. APMIS Suppl 40: 25-34
16. Kawamata T, Tooyaa I, Yamada T, Walker DG, McGeer PL (1993) Lactotransferrin immunocytochemistry in Alzheimer and normal brain. AJP 142: 1574-1585
17. Kleine TO, Hackler R, Zöfel P (1993) Age-related alterations of the blood-brain-barrier (bbb) permeability to protein moelcules of different size. Z Gerontol 26: 256-259
18. Li JJ, Surini M, Catsicas S, Kawashima E, Bouras C (1995) Age-dependent accumulation of advanced glycosylation end products in human neurons. Neurobiol Aging 16: 69-76
19. Maillard LC (1912) Action des acides aminés sur les sucres; formation des melanoides par voie méthodique. C R Hebd Séances Acad Sci 154: 66-68
20. Mattson MP, Carney JW, Butterfield DA (1995) A tombstone in Alzheimer's? Nature 373: 481
21. Monnier VM, Cerami A (1981) Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Science 211: 491-493
22. Münch G, Taneli Y, Schraven E, Schindler U, Schinzel R, Palm D, Riederer P (1994) The cognition-enhancing drug Tensilsetam is an inhibitor of protein crosslinking by advanced glycosylation. J Neural Transm Park Dis Dement Sect 8: 193-208
23. Richardson JS (1993) Free radicals in the genesis of Alzheimer's disease. Ann N Y Acad Sci 695: 73-76
24. Riederer P, Blum-Degen D, Taneli Y, Frölich L, Hover S, Gsell W, Götz ME, Münch G, Beckmann H (1994) Nicht-Amyloid-Hypothesen zur Àtiopathogenese der Alzheimerschen Erkrankung. Fortschr Neurol Psychiatr [Suppl 2] 62: 55-56
25. Schmidt AM, Mora R, Cao R, Yan SD, Brett J, Ramakrishnan R, Tsang TC, Simionescu M, Stern D (1994) The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide. J Biol Chem 269: 9882-9888
26. Shaw PJ (1992) Excitatory amino acid neurotansmission, excitotoxicity and excitotoxins. Curr Opin Neurol Neurosurg 5: 383-390
27. Smith MA, Taneda S, Richey PL, Miyata S, Yan SD, Stern D, Syre LM, Monnier VM, Perry G (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91: 5710-5714
28. Smith MA, Sayre LM, Monnier VM, Perry G (1995) Radical AGEing in Alzheimer's disease. TINS 18: 172-176
29. Smith MA, Sayre LM, Vitek MP, Monnier VM, Perry G (1995) Early AGEing and Alzheimer's. Nature 374: 316
30. Thome J, Baumer A, Kornhuber J, Rösler M, Riederer P (1995) Alpha-1-antichymotrypsin bi-allele polymorphism, apolipoprotein-E tri-allele polymorphism and genetic risk of Alzheimer's syndrome. J Neural Transm Park Dis Dement Sect 10: 207-212
31. Thome J, Münch G, Müller R, Schinzel R, Kornhuber J, Blum-Degen D, Sitzmann L, Rösler M, Heidland A, Riederer P (1996) Advanced glycation endproducts-associated parameters in the peripheral blood of patients with Alzheimer's syndrome. Life Sci 59: 679-685
32. Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer's disease. Proc Natl Acad Sci USA 91: 4766-4770
33. Vlassara H, Brownlee M, Cerami A (1985) High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanisms for the removal of senescent macromolecules. Proc Natl Acad Sci USA 82: 5588-5592
34. Vlassara H, Bucala R, Striker L (1994) Biology, biologic, and clinical implications for diabetes and aging. Lab Invest 70: 138-151
35. Walsh TJ, Opello KD (1992) Neuroplasticity, the aging brian, and Alzheimer's disease. Neurotoxicology 13: 101-110
36. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D, Stern D (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptor/binding protein. J Biol Chem 269: 9889-9897